NSI To Begin Papnet Primary Screening Clinical Trials This Month
This article was originally published in The Gray Sheet
Executive Summary
Following recent protocol discussion with FDA, Neuromedical Systems, Inc. anticipates a July start of U.S. clinical trials to collect data in support of a primary screening indication for the Papnet automated Pap smear screening system.